Zonisamide for Weight Reduction in Obese Adults | Zendy

Kishore M. Gadde | Zendy; Mariko F. Kopping | Zendy; Henry R. Wagner | Zendy; Gretchen M. Yonish | Zendy; David B. Allison | Zendy; George A. Bray | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Zonisamide for Weight Reduction in Obese Adults

Author(s) -

Kishore M. Gadde,

Mariko F. Kopping,

Henry R. Wagner,

Gretchen M. Yonish,

David B. Allison,

George A. Bray

Publication year - 2012

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/2013.jamainternmed.99

Subject(s) - zonisamide , medicine , placebo , weight loss , body mass index , tolerability , canagliflozin , dosing , obesity , randomized controlled trial , diabetes mellitus , topiramate , adverse effect , type 2 diabetes , endocrinology , epilepsy , alternative medicine , pathology , psychiatry

Obese individuals who have failed to achieve adequate weight loss with lifestyle changes have limited nonsurgical therapeutic options. We evaluated the efficacy and tolerability of zonisamide, an antiepileptic drug, for enhancing weight loss in obese patients receiving diet and lifestyle guidance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research